Skip to main content

Distinguished Speaker Series | Maureen A. McCall, PhD

-
Location
https://ucihealth.zoom.us/j/92801383742?pwd=vfI4WBKGwibdfbtyznYWvAbSg3CccO.1
Event Type

Add to Calendar: Outlook | Google | iCal

The Center for Translational Vision Research Distinguished Speaker Series, also known as "Friday Seminars" showcases innovative research across the world. The seminar series has now been expanded to include lectures by experts on topics ranging from Ophthalmology, Genetics, Biochemistry, Neurobiology, Imaging, Computational Sciences to Novel Ophthalmic Treatments.

All talks are hybrid. You can join us in person at

The Falling Leaves Foundation Building, Main Entrance Level

Conference Room (2nd Floor by signage)

847 Health Sciences Quad

You can also join us by zoom. Zoom link and information are on your right and in the calendar links above.

January 9, 2026 | Maureen A. McCall, PhD

Successful treatments for adRP due to rhodopsin mutations using a large animal model harboring a human P23H Rhodopsin mutation

 

Learn More About the Distinguished Speaker Series

Featured


Maureen A. McCall, PhD
Maureen A. McCall, PhD
  • Professor & Vice Chair for Research, Department of Ophthalmology & Visual Sciences, Kentucky Lions Eye Research Endowed Chair, University of Louisville

Dr. Maureen A. McCall, Ph.D., is the Scotts Chair in Ophthalmology and Visual Sciences and a Professor of Ophthalmology and Physiology at the University of Louisville, where she is internationally recognized for her contributions to retinal neurophysiology and vision restoration research. Her work investigates how retinal neurons encode visual information in both healthy and diseased states, with a focus on developing and evaluating therapies for retinal degenerations. Dr. McCall’s laboratory integrates electrophysiology, computational analysis, and preclinical models to study how retinal circuits adapt to photoreceptor loss and how these changes influence the effectiveness of emerging treatments such as retinal prostheses, optogenetics, and gene-based interventions. Her research has been instrumental in advancing our understanding of functional remodeling in the degenerating retina and in guiding strategies to improve visual outcomes for patients with inherited retinal diseases. A dedicated mentor and scientific leader, Dr. McCall has served in key roles within national vision research organizations and has contributed extensively to NIH study sections and collaborative research networks. Her career reflects a longstanding commitment to bridging fundamental neuroscience with translational applications, fostering interdisciplinary approaches that advance therapies for blinding retinal disorders.